Placement Completed
Tryptamine Therapeutics placement
A$6.1m raised
Announced 5 Nov 2025 · ASX: TYP
Advisers
Tryptamine Therapeutics
Issuer
Not disclosed
Lead managers
- Lead manager
- Issuer
- Tryptamine Therapeutics
- Completed
- 18 Nov 2025
- Sector
- Biotech and pharmaceuticals
Similar deals
- Syntara placement Apr 2026 · A$8m · Biotech and pharmaceuticals
- Emyria placement Nov 2025 · A$8m · Biotech and pharmaceuticals
- Nyrada placement Aug 2025 · A$8.3m · Biotech and pharmaceuticals
- Chimeric Therapeutics placement Dec 2025 · A$8.4m · Biotech and pharmaceuticals
- Chimeric Therapeutics placement Dec 2025 · A$4.4m · Biotech and pharmaceuticals
Sources
- 5 Nov 2025 $6.1m in new funding to accelerate clinical development ASX
- 18 Nov 2025 Application for quotation of securities - TYP ASX